Company Filing History:
Years Active: 2025
Title: Manuel Mihalic: Innovator in Pharmaceutical Chemistry
Introduction
Manuel Mihalic is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on rapamycin derivatives. His research focuses on developing compounds that can be used in various medical applications.
Latest Patents
Manuel Mihalic holds a patent for rapamycin derivatives, specifically the disclosure of 32-deoxo-rapamycin derivatives of Formula (I). This patent includes pharmaceutically acceptable salts, pharmaceutical compositions, and combinations that utilize these compounds. The methods described in his patent aim to treat various diseases and disorders, showcasing the potential impact of his work on healthcare.
Career Highlights
Mihalic is currently employed at Novartis AG, a leading global healthcare company. His role at Novartis allows him to collaborate with other experts in the field and contribute to groundbreaking research and development in pharmaceuticals.
Collaborations
Some of his notable coworkers include Simone Bonazzi and Michael Connolly. Their collaboration enhances the innovative environment at Novartis AG, fostering advancements in pharmaceutical research.
Conclusion
Manuel Mihalic's contributions to pharmaceutical chemistry, particularly through his patent on rapamycin derivatives, highlight his role as an influential inventor in the industry. His work has the potential to lead to significant advancements in medical treatments.